股东减持

Search documents
创业慧康:飞利浦减持致持股降至10%以下
Xin Lang Cai Jing· 2025-09-10 12:14
Core Viewpoint - Philips (China) Investment Co., Ltd., a shareholder holding more than 5%, has initiated a share reduction plan for Chuangye Huikang Technology Co., Ltd. [1] Group 1 - On September 9, Philips reduced its holdings by 560,500 shares, representing 0.036292% of the total share capital after excluding shares in the company's repurchase account [1] - Following this equity change, Philips' shareholding has decreased to 9.999996%, falling below the 10% threshold [1] - The company does not have a controlling shareholder or actual controller, and this change will not affect the company's control, governance structure, or ongoing operations [1] Group 2 - Philips has not yet completed its pre-disclosed share reduction plan and will continue to disclose progress [1]
物产金轮:股东南通金轮控股拟减持不超3%公司股份
Xin Lang Cai Jing· 2025-09-10 12:07
Core Viewpoint - The shareholder Nantong Jinlun Holdings Co., Ltd. plans to reduce its stake in Wuchan Jinlun by up to 6.2428 million shares, representing no more than 3% of the company's total share capital, within three months after the announcement [1] Summary by Relevant Sections - **Share Reduction Plan** - The reduction will occur through centralized bidding and block trading methods [1] - The selling price will be determined based on the market price at the time of the reduction [1] - The reason for the reduction is stated as the company's operational needs [1] - **Market Conditions** - Jinlun Holdings will decide whether to implement the share reduction plan based on market conditions and stock price [1]
天正电气实控人拟套现超9180万!年内股价先涨37%后跌3%
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-10 11:49
Group 1 - The actual controller and chairman of the company, Gao Tianle, along with his family members, plan to reduce their holdings in the company, potentially cashing out approximately 91.83 million yuan [1] - Gao Tianle intends to reduce up to 8.073 million shares, representing no more than 1.6% of the total share capital, while his family members plan to reduce 3.0285 million shares and 825,000 shares, representing 0.6% and 0.16% respectively [1] - As of the announcement, Gao Tianle and his family hold a combined 42.78% of the company's shares, and this reduction plan does not change their actual control over the company [1] Group 2 - The company's financial performance has shown volatility in recent years, with total revenue for 2021 to 2024 being 2.922 billion yuan, 2.437 billion yuan, 2.879 billion yuan, and 2.919 billion yuan, with year-on-year growth rates of 18.14%, -16.60%, 18.14%, and 1.38% respectively [2] - The net profit attributable to the parent company for the same period was 109 million yuan, 44.44 million yuan, 162 million yuan, and 121 million yuan, with year-on-year changes of -55.86%, -58.58%, 258.34%, and -24.94% respectively [2] - In the first half of 2025, the company reported a revenue of 1.455 billion yuan, a decrease of 4.96%, while the net profit attributable to the parent company increased by 10.24% to 81.89 million yuan [2] - The company attributes its performance fluctuations to the impact of the real estate sector and local fiscal constraints, despite growth in sectors like new energy and communications, with a notable 180% increase in the charging and swapping industry [2]
楚天龙:温州一马企业管理中心拟3个月内减持3.00%
Xin Lang Cai Jing· 2025-09-10 11:27
楚天龙公告,持股1804.03万股、占3.91%的股东温州一马企业管理中心(有限合伙)因资金需求,计划 自公告日起十五个交易日后的3个月内,即2025年10月10日至2026年1月9日,通过集中竞价或大宗交易 方式合计减持不超过1383.41万股,占公司总股本3.00%;采取大宗交易的,在任意连续90个自然日内减 持股份总数不超过公司总股本2%,集中竞价方式减持总数不超过1%,减持价格视市场确定。 ...
绿盟科技:网安基金减持0股
Xin Lang Cai Jing· 2025-09-10 11:17
Summary of Key Points - The major shareholder, China Electronics Technology Group Corporation (Chengdu) Cybersecurity Equity Investment Fund Partnership (Limited Partnership), originally planned to reduce its holdings from June 9, 2025, to September 8, 2025, by up to 23.9793 million shares, which represents 3% of the company's total share capital [1] - As of the end of the reduction period, the actual reduction was 0 shares, and the shareholder continues to hold 55.9841 million shares, maintaining a shareholding ratio of 7.00% [1]
嘉和美康(688246.SH):股东赛富璞鑫拟减持不超1.94%股份
Ge Long Hui A P P· 2025-09-10 10:12
格隆汇9月10日丨嘉和美康(688246.SH)公布,公司于2025年9月10日收到赛富璞鑫出具的《关于股东减 持计划的告知函》,因股东流动性需求,股东赛富璞鑫计划根据市场情况拟通过集中竞价方式减持其持 有的公司股份不超过267.25万股,即不超过公司总股本的1.94%。自本公告披露之日起3个交易日后的90 天内进行。 ...
大北农实控人拟减持套现3.69亿 此前已累计套现60亿元
Sou Hu Cai Jing· 2025-09-10 05:57
Summary of Key Points Core Viewpoint - The company Dabeinong (002385.SZ) announced a share reduction plan by its controlling shareholder, Shao Genhuo, who intends to reduce his holdings by up to 85,607,400 shares, representing 1.99% of the total share capital, over a period of three months starting from 15 trading days after the announcement [1]. Group 1: Share Reduction Details - Shao Genhuo plans to reduce his holdings through block trades and centralized bidding, with a maximum of 42,803,700 shares to be sold via each method [1]. - Following the reduction, Shao Genhuo will still hold 977,200,026 shares, which is 22.73% of the total share capital [1]. - The estimated cash amount from this reduction, based on the closing price of 4.31 yuan on September 9, is approximately 369 million yuan [1]. Group 2: Historical Shareholding Changes - Shao Genhuo initially held 178 million shares, accounting for 44.49% of the total share capital, and has cumulatively reduced his holdings by 773 million shares since May 2019, realizing approximately 5.978 billion yuan [2]. - Recent reductions include selling 4.4 million shares for 41.448 million yuan on February 9, 2022, and 30.9 million shares for 129.162 million yuan on February 25, 2025, which brought his holding percentage down to 22.87% [4][5]. - The total cash realized from all reductions, including the current plan, amounts to approximately 6.347 billion yuan [5]. Group 3: Company Financial Activities - Dabeinong recently issued 211,480,362 shares to specific investors, raising approximately 699.999 million yuan, with a net amount of about 692.606 million yuan after deducting issuance costs [5]. - The issuance price was set at 3.31 yuan per share, with notable investors including Nord Fund Management and UBS AG [5].
诚达药业原始股东或套现6.34亿离场 净利降49%股价较发行价跌超60%
Chang Jiang Shang Bao· 2025-09-07 23:17
Core Viewpoint - Chengda Pharmaceutical (301201.SZ) is experiencing poor performance, leading to continuous share reductions by original shareholders, particularly Shenzhen Qianhai Shengtai Investment Enterprise, which plans to sell up to 11 million shares, potentially cashing out 316 million yuan [1][3][9]. Group 1: Shareholder Actions - Shenzhen Qianhai Shengtai plans to reduce its holdings by up to 11 million shares, representing 7.27% of the company's total shares, within three months starting from September 29, 2025 [2][3]. - Over the past two and a half years, Qianhai Shengtai has reduced its holdings in Chengda Pharmaceutical, cashing out a total of 634 million yuan [1][9]. - The latest reduction plan follows a series of previous reductions, with Qianhai Shengtai having already cashed out 318 million yuan from earlier sales [8][9]. Group 2: Company Performance - For the first half of 2025, Chengda Pharmaceutical reported revenue of 182 million yuan, an increase of 11.24% year-on-year, but net profit fell by 49.06% to 12.82 million yuan [11][12]. - The company's stock price has dropped over 60% from its initial public offering price of 72.69 yuan, with the current price at 28.74 yuan [9][10]. - Chengda Pharmaceutical's revenue and net profit have shown a declining trend over the past few years, with a notable loss of 28.1 million yuan in 2024, marking the first loss since 2010 [12][13]. Group 3: Business Challenges - The decline in revenue is attributed to a 33.22% drop in sales of raw materials, particularly due to clients overstocking in anticipation of national centralized procurement [12][13]. - The CDMO (Contract Development and Manufacturing Organization) segment also faced a 37.65% decline in sales due to increased competition and global economic uncertainties [12][13]. - Chengda Pharmaceutical aims to expand its market presence and enhance its brand value through various promotional activities and by deepening relationships with existing clients [13].
炒股软件公司董事长公告:我将适度减持股份,“让渡市场参与机会”!他低吸高抛有望大赚近2亿元
Mei Ri Jing Ji Xin Wen· 2025-09-07 15:58
而股东凯士顺的减持则是为了自身资金需要。 每经编辑|金冥羽 9月5日晚间,同花顺(300033.SZ)发布关于控股股东、持股5%以上股东减持股份预披露的公告。 公告称,公司控股股东、实际控制人、持有公司36.13%股份的大股东、董事长易峥,持有公司8.96%股份的股东杭州凯士顺科技有限公司(下称"凯士 顺"),拟自本公告发布之日起15个交易日后的三个月内(2025年9月29日—2025年12月28日),以集中竞价交易方式或大宗交易方式合计减持本公司股份 合计不超过138.31万股(占公司总股本的0.26%)。 对于减持目的,公告表示,实际控制人易峥阶段性增持目标已圆满完成,此前通过低位增持有效稳定了股价,当前的减持是对既定目标的落实。实际控制 人将通过减持优化个人资源配置,从而将更多精力聚焦于公司战略布局和主营业务发展,助力公司价值的持续提升,以回报广大股东的长期信任。同时, 通过适度减持,旨在让渡市场参与机会,释放流动性,激活市场活力,为后续市值管理创造更有利的空间。 | 股东 | 拟减持股份数量 | 拟减持股份占股本比例 | | --- | --- | --- | | 易峥 | 684, 000 | 0. ...
高位接盘邀请函?同花顺董事长拟套现2亿!低位买高位卖!自称“让渡市场参与机会”
Ge Long Hui A P P· 2025-09-07 11:59
据悉,同花顺董事长拟减持的68.4万股股份来源于其增持。2022年4月,同花顺董事长花费5009.9万元增持了公司68.4万股股份。按照上周五收盘价361.5元/ 股计算,其增持的这部分股份已经赚了近2亿元。 对于减持原因,公告解释称凯士顺是"自身资金需要",而易峥的减持理由则颇为新颖:一是"阶段性增持目标已圆满完成",二是"让渡市场参与机会,释放 流动性,激活市场活力",这种说法迅速引发热议。 有投资者调侃这是"高位接盘邀请函",还有股民则表示"要我是股东,我都想把公司卖给你们,这个价格卖赚死了。""减持就减持吧,关键这话说得,像对 我们的一种恩赐。"市场对此次减持的影响存在显著分歧。乐观者认为"利空出尽",预计周一股价将高开;悲观者则预期股价大幅低开。 格隆汇9月7日|同花顺(300033.SZ)9月6日发布公告,公司实控人兼董事长易峥及一致行动人计划在未来三个月内减持不超过138.31万股,占公司总股本 0.26%。以公告日收盘价361.5元计算,此次减持套现规模高达5亿元,其中易峥个人即可套现2.48亿元。 | 股东 | 拟减持股份数量 | 拟减持股份占股本比例 | | --- | --- | --- ...